Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab to Present Phase 2 Clinical Data of CD47 Antibody Lemzoparlimab at ESMO Congress 2022 2022-07-18 20:00
OliPass Moves Forward to Second Stage of Phase 2a Trial for Pain Killer OLP-1002 2022-07-18 20:00
Samsung Biologics to purchase land for its second Bio Campus 2022-07-18 19:00
Lunit to be Listed on KOSDAQ next week 2022-07-14 21:00
Bridge Biotherapeutics to Present Interim Clinical Data from Ongoing Phase 1 Study of BBT-176 at the World Conference of Lung Cancer 2022-07-13 06:30
KAZIA LAUNCHES NEW SCIENTIFIC ADVISORY BOARD COMPRISED OF WORLD-LEADING EXPERTS IN BRAIN CANCER 2022-07-12 20:15
iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates 2022-07-12 10:06
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report 2022-07-11 19:00
Industry Empowered by Science: Guangming Science City Lures Talent Globally 2022-07-08 15:38
Biotech Startup Noul Releases 2021 Sustainability Report 2022-07-08 15:00
NEW EARLY BREAST CANCER DRUG TO REDUCE RISK OF RECURRENCE OR DEATH NOW AVAILABLE IN THE PHILIPPINES 2022-07-08 09:28
SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972 2022-07-07 20:00
Zhiyi Biotech Raised $45 Million in Series B Funding Round to Accelerate the Clinical Development of LBPs Pipelines 2022-07-07 17:45
WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility 2022-07-07 08:00
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy 2022-07-06 23:00
US FDA AWARDS RARE PEDIATRIC DISEASE DESIGNATION (RPDD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER 2022-07-06 19:00
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007 2022-07-06 12:00
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 2022-07-06 04:16
EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement 2022-07-05 15:00
ClinChoice Raises $150 mm Series E Round Financing, Further Strengthening its Global Services Capabilities 2022-07-05 09:20
1 76 77 78 79 80 222